Advertisement

Topics

Prosidion Ltd Company Profile

03:14 EST 14th December 2018 | BioPortfolio

(OSI) Prosidion is the diabetes and obesity business group within OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) dedicated to the discovery and development of novel drugs for the treatment of type 2 diabetes and obesity. (OSI) Prosidion's lead compound PSN9301 is a Dipeptidyl Peptidase IV (DP-IV) inhibitor currently in Phase II clinical trials. PSN357, a glycogen phosphorylase inhibitor, is undergoing Phase IIa clinical studies and PSN010, a glucokinase activator, has recently entered Phase I clinical trials. (OSI) Prosidion owns or has licensing rights to a portfolio of DP-IV medical use patents with claims covering DP-IV as a target for anti-diabetes therapy and the use of combinations of DP-IV inhibitors with other anti-diabetes drugs such as metformin. A number of non-exclusive licenses to the patent estate have been granted to major pharmaceutical companies. (OSI) Prosidion operates through OSI's wholly-owned subsidiary, Prosidion Limited, in Oxford, UK

Location

Watlington Road
Oxford
Oxfordshire
OX4 6LT
United Kingdom

Contact

Phone: 44 (0)1865 782600
Fax: 44 (0)1865 782601
Email: Info@Prosidion.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Prosidion Ltd

(OSI) Prosidion is the diabetes and obesity business group within OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) dedicated to the discovery and development of novel drugs for the treatment of type 2 diabetes...

Aestus Therapeutics and Prosidion Ltd.

Aestus Therapeutics, Inc. is a translational medicine company focused on serious neurological diseases. Capitalizing on genomic data analysis to discover novel links between these...

OSI Pharmaceuticals

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality o...

More Information about "Prosidion Ltd" on BioPortfolio

We have published hundreds of Prosidion Ltd news stories on BioPortfolio along with dozens of Prosidion Ltd Clinical Trials and PubMed Articles about Prosidion Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prosidion Ltd Companies in our database. You can also find out about relevant Prosidion Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record